There is some evidence that probiotics prevent necrotizing enterocolitis in very low birth weight infants (birth weight between 1000 and 1500 grams), but more studies are needed, the report says.
What does VLBWI stand for?
VLBWI stands for Very Low Birth Weight Infant
This definition appears rarely and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
- Very Long Baseline Polarimetry (astronomy)
- very low birth-rate
- Very Low Bit Rate
- Virginia Law and Business Review
- Victory Life Bible Training Centre (Perth, Australia)
- Vesa Local Bus
- Vereniging Leraren Beeldende Vakken (Dutch: Visual Arts Teachers Association; Netherlands)
- Very Low Bitrate Video
- Very Low Bit rate Video Telephony
- Very Low Birth Weight (less than 1500 grams)
- Valencia, Spain - Valencia (Airport Code)
- Validation Life Cycle
- Valley Leisure Centre (UK)
- Valley Library Consortium (Saginaw, MI)
- Vancouver Language Centre (Mexico)
- VanderLugt Correlator
- Variable Length Codeword
- Variable Length Coding
- Variable-Length Capacity
- Vera List Center for Arts and Politics (New York, NY)
Samples in periodicals archive:
While feeding unsupplemented mother's own milk to very low birth weight infants (birth weight <1500 g) has been shown to result in slower weight and length gains (12, 16), the implications of this slower growth are unclear and there is not enough evidence to assess if it increased the risk of malnutrition.
Very low birth weight infants are significantly more likely to survive when delivered in hospitals with high-level neonatal intensive care units that care for more than 100 such newborns annually than are those delivered in comparable facilities that provide care to fewer than 100 such children every year.
6, respectively), more than twice the odds of bearing a very low birth weight infant (2.
For example, about 3 percent of very low birth weight infants will develop spontaneous intestinal perforation, and the risk is approximately twofold greater if they have been treated with indomethacin.
aureus) in very low birth weight infants that weigh between 500 and 1,250 grams at birth.
Among women receiving combination therapy, however, users of protease inhibitors may be more likely than nonusers to have a very low birth weight infant (odds ratio, 3.
The Company's most advanced product candidate is Veronate, which is currently being evaluated in a Phase III trial for the prevention of hospital-associated infections in very low birth weight infants.